undamentalytics Newsletter

Marchesi Vincent T: insider trades

Director at Exelixis, Inc. 3 open-market purchases and 10 sales not made under a pre-set plan, reported from June 15, 2012 to May 17, 2021.

Would copying Marchesi Vincent T’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved −23.0% against the index over 12 months on average (a negative figure means selling was the right call); 90% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Marchesi Vincent T: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 10 −13.2% −11.4% 80% 6 −5.25 0.003 Strong evidence: seller right
Sales, 12 months after the report 10 −23.0% −24.6% 90% 6 −2.74 0.041 Some evidence: seller right
Sales, 12 months after the trade 10 −24.2% −24.4% 90% 6 −3.16 0.025 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Exelixis, Inc. EXEL —310June 15, 2012May 17, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 17, 2021May 14, 2021 EXEL Sale $1,001,600 −30.1%−15.4%−19.1%
February 24, 2021February 22, 2021 EXEL Sale $537,122 −8.0%−22.0%−24.8%
November 25, 2020November 24, 2020 EXEL Sale $740,074 +6.7%−42.4%−36.2%
May 22, 2020May 21, 2020 EXEL Sale $985,600 −26.2%−50.1%−43.6%
May 13, 2020May 11, 2020 EXEL Sale $789,000 −29.7%−45.3%−53.8%
February 22, 2019February 22, 2019 EXEL Sale $886,875 −10.6%−27.2%−23.9%
August 17, 2018August 15, 2018 EXEL Sale $780,000 +5.0%+17.1%+7.4%
March 7, 2018March 6, 2018 EXEL Sale $370,950 −23.1%−7.4%−8.7%
March 10, 2017March 10, 2017 EXEL Sale $879,200 −12.2%−5.1%−4.8%
September 19, 2014September 17, 2014 EXEL Purchase $34,200 not yetnot yetnot yet
December 20, 2012December 20, 2012 EXEL Purchase $18,720 not yetnot yetnot yet
December 19, 2012December 17, 2012 EXEL Purchase $28,335 not yetnot yetnot yet
June 15, 2012June 14, 2012 EXEL Sale $35,911 −3.5%−31.7%−34.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Marchesi Vincent T traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.